These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 11175425)

  • 41. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
    WieroĊ„ska JM; Papp M; Pilc A
    Pol J Pharmacol; 2001; 53(5):517-25. PubMed ID: 11990071
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discriminative stimulus effects of the novel anxiolytic buspirone.
    Ator NA
    Behav Pharmacol; 1991 Feb; 2(1):3-14. PubMed ID: 11224042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice.
    Troisi 2nd JR; Critchfield TS; Griffiths RR
    Behav Pharmacol; 1993 Jun; 4(3):217-230. PubMed ID: 11224189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one].
    Licata SC; Platt DM; Cook JM; Sarma PV; Griebel G; Rowlett JK
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1118-25. PubMed ID: 15687371
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors.
    Popik P; Kostakis E; Krawczyk M; Nowak G; Szewczyk B; Krieter P; Chen Z; Russek SJ; Gibbs TT; Farb DH; Skolnick P; Lippa AS; Basile AS
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1244-52. PubMed ID: 16971504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of a benzodiazepine receptor agonist and corticotropin-releasing hormone receptor antagonists on long-term foot-shock-induced increase in defensive withdrawal behavior.
    Bruijnzeel AW; Stam R; Wiegant VM
    Psychopharmacology (Berl); 2001 Nov; 158(2):132-9. PubMed ID: 11702086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of gamma-hydroxybutyrate on punished responding in pigeons.
    Frawly K; McMillan DE
    Behav Pharmacol; 2008 Feb; 19(1):77-9. PubMed ID: 18195597
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
    McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
    Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rapid induction of tolerance to the antipunishment effects of ethanol.
    Koob GF; Wall TL; Schafer J
    Alcohol; 1987; 4(6):481-4. PubMed ID: 3435637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of acute or chronic carbamazepine on experimentally-induced conflict in the rat.
    Almeida RN; Leite JR
    Psychopharmacology (Berl); 1990; 100(2):227-9. PubMed ID: 2305010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug treatment of anxiety: implications for animal models.
    Lader M
    Behav Pharmacol; 1989; 1(1):95-100. PubMed ID: 11175392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacology and anxiety: inadequacies of current experimental approaches and working models.
    Bignami G
    Pharmacol Biochem Behav; 1988 Apr; 29(4):771-4. PubMed ID: 2901115
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A device for measuring food-magazine behavior in the pigeon.
    Fernie RW
    J Exp Anal Behav; 1971 Nov; 16(3):409-10. PubMed ID: 16811557
    [No Abstract]   [Full Text] [Related]  

  • 56. The Harvard Pigeon Lab in context.
    Hineline PN
    J Exp Anal Behav; 2002 May; 77(3):383-5. PubMed ID: 12083696
    [No Abstract]   [Full Text] [Related]  

  • 57. Pigeon Lab notable experience.
    Azrin NH
    J Exp Anal Behav; 2002 May; 77(3):373. PubMed ID: 12083689
    [No Abstract]   [Full Text] [Related]  

  • 58. Behavioral and neurobiological mechanisms of punishment: implications for psychiatric disorders.
    Jean-Richard-Dit-Bressel P; Killcross S; McNally GP
    Neuropsychopharmacology; 2018 Jul; 43(8):1639-1650. PubMed ID: 29703994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparison of chlordiazepoxide, bretazenil, L838,417 and zolpidem in a validated mouse Vogel conflict test.
    Mathiasen L; Mirza NR
    Psychopharmacology (Berl); 2005 Nov; 182(4):475-84. PubMed ID: 16133136
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Anticonflict effects of buspirone and chlordiazepoxide in pigeons under a concurrent schedule with punishment and a changeover response.
    Wojnicki FH; Barrett JE
    Psychopharmacology (Berl); 1993; 112(1):26-33. PubMed ID: 7871007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.